Palette Life Sciences celebrates twenty years of deflux treatment for vesicoureteral reflux (VUR) in the United States
Deflux has enabled thousands of children to receive a highly effective, minimally invasive, same-day treatment for VUR
Deflux has enabled thousands of children to receive a highly effective, minimally invasive, same-day treatment for VUR
Join leading researchers online to explore the latest advances and common challenges in the field of breath biopsy
Guest blog by PromoCell explores if HLA-type could be a key differentiator in disease outcomes, and in developing treatments
Amulet device is the first minimally invasive option approved for left atrial appendage occlusion that does not require blood-thinning medication
Watch this on-demand webinar to explore a complete workflow for the development of targeted biomarker measurements for precision medicine
R&D manager Yahya Nuruddeen supervises multiple research teams. Here, he explains how reviews have helped him make the right decision for their laboratories
Obtaining two vaccine doses remains the most effective way to ensure protection against the COVID-19 Delta variant
Patients with underlying heart problems are more than four times as likely to die from COVID-19
Dr. Erik Tillman shares his virtual company’s quest to find an effective new life-changing treatment for non-alcoholic steatohepatitis
Sunil Patel reveals the key technology behind reliable pharmaceutical formulation and finished product analysis at Intas Pharmaceuticals
Researchers found that longer dosing intervals led to higher antibody levels and a higher proportion of ‘helper’ T cells
Findings explain higher risk of heart attack in people with diabetes, even after treatment
Discover the impact of the COVID-19 pandemic on a clinical research facility and the future of clinical trial recruitment
Mixed schedules involving Pfizer-BioNTech and Oxford-AstraZeneca generate strong immune response against SARS-CoV2 spike IgG protein
Learn about the large scale COVID-19 PCR testing program set up by the government of Luxembourg
Tested on human blood in the lab, the selective nanocapsules could reduce the side effects of a major blood clot-dissolving drug, which include bleeding on the brain
Deborah McManus and Gareth Satchell, Drug Development Solutions, LGC
Top talks presenting the latest technologies, research and applications are now available on demand
Watch world-leading clinical scientists and healthcare professionals online, June 22-23, to discover the latest tools and techniques advancing COVID-19 diagnostic testing, cardiovascular treatments, point-of-care and more
The fast time-to-result includes a pretreatment process to inactivate the virus as a safeguard for laboratory staff handling the samples